Sandoz-Irbesartan/HCT Product Recall (2021-05-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Sandoz Irbesartan/HCT 150/12.5 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| JK7459, JK7460, JM3516, JM3517, JR7821, JU7500, JU7501, JU7502, JU7503, JY0147, JE2529, JM4631, JZ2686 | B. Sandoz Irbesartan/HCT 300/12.5 mg Tablet | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02337436 | Tablet | Irbesartan 300 mg |
| JB0221, JB0222, JC4402, JC4404, JH2487, JR7112, JR7833, JU3181, JW9512, JW9513, KC1750, JE1833, JR8726 | C. Sandoz Irbesartan/HCT 300/25 mg Tablet | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02337444 | Tablet | Irbesartan 300 mg |
| JF5840, JN4197, JN4971, JU3217, JV2167, JF8892, JN4191 | A. Sandoz Irbesartan/HCT 150/12.5 mg Tablet | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02337428 | Tablet | Irbesartan 150 mg |
-
Sandoz Irbesartan/HCT 150/12.5 mg Tablet
-
Sandoz Irbesartan/HCT 300/12.5 mg Tablet
-
Sandoz Irbesartan/HCT 300/25 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.